Cargando…
The gut microbiome switches mutant p53 from tumour-suppressive to oncogenic
Somatic mutations in p53, which inactivate the tumour-suppressor function of p53 and often confer oncogenic gain-of-function properties, are very common in cancer(1,2). Here we studied the effects of hotspot gain-of-function mutations in Trp53 (the gene that encodes p53 in mice) in mouse models of W...
Autores principales: | Kadosh, Eliran, Snir-Alkalay, Irit, Venkatachalam, Avanthika, May, Shahaf, Lasry, Audrey, Elyada, Ela, Zinger, Adar, Shaham, Maya, Vaalani, Gitit, Mernberger, Marco, Stiewe, Thorsten, Pikarsky, Eli, Oren, Moshe, Ben-Neriah, Yinon |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7116712/ https://www.ncbi.nlm.nih.gov/pubmed/32728212 http://dx.doi.org/10.1038/s41586-020-2541-0 |
Ejemplares similares
-
Widespread parainflammation in human cancer
por: Aran, Dvir, et al.
Publicado: (2016) -
β-TrCP Inhibition Reduces Prostate Cancer Cell Growth via Upregulation of the Aryl Hydrocarbon Receptor
por: Gluschnaider, Udi, et al.
Publicado: (2010) -
p53 elevation in human cells halt SV40 infection by inhibiting T-ag expression
por: Drayman, Nir, et al.
Publicado: (2016) -
Genome-Wide Analysis of Androgen Receptor Targets Reveals COUP-TF1 as a Novel Player in Human Prostate Cancer
por: Perets, Ruth, et al.
Publicado: (2012) -
The Type III Secretion Effector NleE Inhibits NF-κB Activation
por: Nadler, Chen, et al.
Publicado: (2010)